Table 4.
Review of literatures about CB-PTA for ISR
| Author (y) | Number of CB-PTA cases | Requirement for additional stenting | Follow-up length (mo) | Number of cases of recurrent ISR after CB-PTA | Procedural complication |
|---|---|---|---|---|---|
| Bendok et al. (2003) [9] | 3 | 1 (33.3) | NA | NA | 0 |
| Tamberella et al. (2004) [10] | 1 | 0 | NA | NA | 0 |
| Levy et al. (2005) [11] | 1 | 0 | 6 | 0 | 0 |
| Setacci et al. (2005) [8] | 5 | 1 (20.0) | 6 (3.5–10) | 0 | 0 |
| Reimers et al. (2006) [12] | 10 | NA | NA | NA | 0 |
| Zhou et al. (2006) [13] | 5 | 1 (20.0) | 8 (3–14) | 1 (20.0) | 0 |
| Shah et al. (2008) [14] | 2 | 0 | 1 | 0 | 0 |
| Heck (2009) [15] | 6 | 0 | 22 (3–36) | 1 (16.7) | 0 |
| Shimozato et al. (2021) [16] | 1 | 0 | NA | NA | 0 |
Values are presented as number only, number (%), or mean (range).
CB-PTA, cutting balloon-percutaneous transluminal angioplasty; ISR, in-stent restenosis; NA, not available.